Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

pharmaphorum

FEBRUARY 26, 2021

Weldon became the Chairman and CEO of J&J in 2002. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government. billion the following February.

Vaccines 126

Vaccines Biosimilars Labelling Communication 126

pharmaphorum

DECEMBER 2, 2020

Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. The deal seemed to be a precursor to Pfizer’s plans to separate its patent-protected medicines business from its off-patent portfolio.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128